BR0211156A - Forma de dosagem de liberação controlada com taxas de liberação variáveis - Google Patents
Forma de dosagem de liberação controlada com taxas de liberação variáveisInfo
- Publication number
- BR0211156A BR0211156A BR0211156-0A BR0211156A BR0211156A BR 0211156 A BR0211156 A BR 0211156A BR 0211156 A BR0211156 A BR 0211156A BR 0211156 A BR0211156 A BR 0211156A
- Authority
- BR
- Brazil
- Prior art keywords
- dosage form
- layer
- tablet core
- controlled release
- varying
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"FORMA DE DOSAGEM DE LIBERAçãO CONTROLADA COM TAXAS DE LIBERAçãO VARIáVEIS". Uma forma de dosagem de liberação controlada com taxas de liberação variáveis compreendendo: 1) um núcleo do comprimido de camada dupla ou de camada múltipla e que pelo menos uma das camadas contém um ou mais ingredientes farmaceuticamente ativos e pelo menos uma das camadas contém um ou mais polímeros controladores de taxa; 2) uma cobertura substancialmente insolúvel estendida sobre o núcleo do comprimido cobrindo a maior parte da superfície do comprimido mas deixando uma porção de uma camada do núcleo do comprimido exposta (camada exposta), a cobertura resultando da deposição eletrostática de um pó compreendendo partículas fundíveis sobre o núcleo do comprimido e fundindo-se as partículas para formar uma película fina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0117618.9A GB0117618D0 (en) | 2001-07-19 | 2001-07-19 | Pharmaceutical dosage form |
PCT/GB2002/003286 WO2003007919A1 (en) | 2001-07-19 | 2002-07-18 | Controlled drug delivery systems providing variable release rates |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0211156A true BR0211156A (pt) | 2004-08-10 |
Family
ID=9918808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0211156-0A BR0211156A (pt) | 2001-07-19 | 2002-07-18 | Forma de dosagem de liberação controlada com taxas de liberação variáveis |
Country Status (14)
Country | Link |
---|---|
US (1) | US20060099257A1 (pt) |
EP (1) | EP1406597A1 (pt) |
JP (2) | JP2005501039A (pt) |
KR (1) | KR20040032857A (pt) |
CN (1) | CN1556697A (pt) |
AU (1) | AU2002317360B2 (pt) |
BR (1) | BR0211156A (pt) |
CA (1) | CA2457308A1 (pt) |
GB (1) | GB0117618D0 (pt) |
IL (1) | IL159876A0 (pt) |
MX (1) | MXPA04000544A (pt) |
RU (1) | RU2004104950A (pt) |
WO (1) | WO2003007919A1 (pt) |
ZA (1) | ZA200401216B (pt) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005507881A (ja) | 2001-09-17 | 2005-03-24 | グラクソ グループ リミテッド | 乾燥粉末医薬製剤 |
PE20050335A1 (es) * | 2003-08-07 | 2005-06-01 | Sb Pharmco Inc | Forma de dosificacion oral que comprende 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona y procedimiento para la preparacion |
US8153159B2 (en) | 2003-09-18 | 2012-04-10 | Cephalon, Inc. | Modafinil modified release pharmaceutical compositions |
US20070259033A1 (en) * | 2003-09-26 | 2007-11-08 | Evangeline Cruz | Controlled release formulations exhibiting an ascending rate of release |
MXPA06003454A (es) * | 2003-09-26 | 2006-08-31 | Johnson & Johnson | Formulaciones de liberacion controlada de analgesicos opioides y no opiodes. |
US8246986B2 (en) | 2003-09-26 | 2012-08-21 | Alza Corporation | Drug coating providing high drug loading |
CA2540047A1 (en) * | 2003-09-26 | 2005-04-07 | Alza Corporation | Oros push-stick for controlled delivery of active agents |
US7553377B1 (en) | 2004-04-27 | 2009-06-30 | Advanced Cardiovascular Systems, Inc. | Apparatus and method for electrostatic coating of an abluminal stent surface |
US7390524B1 (en) | 2004-05-20 | 2008-06-24 | Advanced Cardiovascular Systems, Inc. | Method for electrostatic spraying of an abluminal stent surface |
ATE401868T1 (de) * | 2004-08-04 | 2008-08-15 | Alza Corp | ZUSAMMENSETZUNG MIT VERZÖGERTER ARZNEIMITTELFREISETZUNG MIT EINEM AUFSTEIGENDEN NULLORDNUNG-FREIGABE-MUSTER; VERFAHREN ZUR HERSTELLUNG EINER SOLCHEN ZUSAMMENSETZUNGß |
US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
WO2006055886A2 (en) * | 2004-11-19 | 2006-05-26 | Smithkline Beecham Corporation | Method for customized dispensing of variable dose drug combination products for individualizing of therapies |
WO2007121188A2 (en) * | 2006-04-10 | 2007-10-25 | Knopp Neurosciences, Inc. | Compositions and methods of using r(+) pramipexole |
US8518926B2 (en) | 2006-04-10 | 2013-08-27 | Knopp Neurosciences, Inc. | Compositions and methods of using (R)-pramipexole |
US8017598B2 (en) | 2006-05-16 | 2011-09-13 | Knopp Neurosciences, Inc. | Compositions of R(+) and S(−) pramipexole and methods of using the same |
EP2497473A1 (en) | 2006-05-16 | 2012-09-12 | Knopp Neurosciences, Inc. | Therapeutically effective amounts of R(+) and S(-) pramipexole for use in the treatment of Parkinson's disease and pharmaceutical compositions thereof |
EP2462926B1 (en) * | 2006-05-23 | 2015-12-30 | Orahealth Corporation | Bi-layer oral adhering tablet with acacia gum adhesive |
US8524695B2 (en) * | 2006-12-14 | 2013-09-03 | Knopp Neurosciences, Inc. | Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same |
US8519148B2 (en) * | 2007-03-14 | 2013-08-27 | Knopp Neurosciences, Inc. | Synthesis of chirally purified substituted benzothiazole diamines |
MX2010008861A (es) * | 2008-02-15 | 2011-02-22 | Sun Pharma Advanced Res Co Ltd | Tableta oral de liberacion controlada con efecto de liberacion masiva reducido. |
TWI542338B (zh) * | 2008-05-07 | 2016-07-21 | 壯生和壯生視覺關懷公司 | 用於活性劑之控制釋放的眼用裝置 |
WO2010014952A2 (en) | 2008-07-31 | 2010-02-04 | Clarke Mosquito Control Products, Inc. | Extended release tablet and method for making and using same |
CA2734095A1 (en) * | 2008-08-14 | 2010-02-18 | Bioneer A/S | Coated tablets with a remaining degradation surface over the time |
EP2334185A4 (en) * | 2008-08-19 | 2011-09-21 | Knopp Neurosciences Inc | COMPOSITIONS AND METHODS FOR USE OF (R) -PRAMIPEXOL |
TWI478712B (zh) | 2008-09-30 | 2015-04-01 | Astellas Pharma Inc | 釋控性醫藥組成物 |
JP2012530723A (ja) * | 2009-06-19 | 2012-12-06 | ノップ ニューロサイエンシーズ、インク. | 筋萎縮性側索硬化症を治療するための組成物及び方法 |
EP2554168B1 (en) | 2010-03-29 | 2018-01-24 | Astellas Pharma Inc. | Controlled release pharmaceutical composition |
EP2481411A1 (en) * | 2011-01-27 | 2012-08-01 | Ratiopharm GmbH | Oral dosage forms for modified release comprising the JAK3 inhibitor tasocitinib |
LT5850B (lt) | 2011-08-31 | 2012-07-25 | Česlovas Paplauskas | Vertikalaus srauto išorinis fazės apgręžiklis garso monitoriams |
US20130096479A1 (en) * | 2011-10-18 | 2013-04-18 | St. Teresa Medical, Inc. | Method of forming hemostatic products |
WO2013090452A1 (en) | 2011-12-12 | 2013-06-20 | Orbis Biosciences, Inc. | Sustained release particle formulations |
US9512096B2 (en) | 2011-12-22 | 2016-12-06 | Knopp Biosciences, LLP | Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds |
US9662313B2 (en) | 2013-02-28 | 2017-05-30 | Knopp Biosciences Llc | Compositions and methods for treating amyotrophic lateral sclerosis in responders |
US9468630B2 (en) | 2013-07-12 | 2016-10-18 | Knopp Biosciences Llc | Compositions and methods for treating conditions related to increased eosinophils |
SI3019167T1 (sl) | 2013-07-12 | 2021-04-30 | Knopp Biosciences Llc | Zdravljenje povišanih ravni eozinofilcev in / ali bazofilcev |
ES2813674T3 (es) | 2013-08-13 | 2021-03-24 | Knopp Biosciences Llc | Composiciones y métodos para el tratamiento de trastornos de células plasmáticas y trastornos prolinfocíticos de células b |
CA2921381A1 (en) | 2013-08-13 | 2015-02-19 | Knopp Biosciences Llc | Compositions and methods for treating chronic urticaria |
WO2015117004A1 (en) * | 2014-01-31 | 2015-08-06 | Board Of Regents, The University Of Texas System | Method for preparing films |
CN115645374B (zh) * | 2022-12-25 | 2024-04-26 | 山东理工职业学院 | 一种硫酸沙丁胺醇片的制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8820353D0 (en) * | 1988-08-26 | 1988-09-28 | Staniforth J N | Controlled release tablet |
DK469989D0 (da) * | 1989-09-22 | 1989-09-22 | Bukh Meditec | Farmaceutisk praeparat |
GB2253164B (en) * | 1991-02-22 | 1994-10-05 | Hoechst Uk Ltd | Improvements in or relating to electrostatic coating of substrates of medicinal products |
IT1264696B1 (it) * | 1993-07-09 | 1996-10-04 | Applied Pharma Res | Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata |
GB9402203D0 (en) * | 1994-02-04 | 1994-03-30 | Smithkline Beecham Plc | Pharmaceutical formulation |
US5582838A (en) * | 1994-12-22 | 1996-12-10 | Merck & Co., Inc. | Controlled release drug suspension delivery device |
WO1996035516A1 (en) * | 1995-05-09 | 1996-11-14 | Colorcon Limited | Electrostatic coating |
DK200000133U3 (da) * | 1999-04-13 | 2000-07-28 | Beecham Pharm Pte Ltd | Ny farmaceutisk formulering |
-
2001
- 2001-07-19 GB GBGB0117618.9A patent/GB0117618D0/en not_active Ceased
-
2002
- 2002-07-18 IL IL15987602A patent/IL159876A0/xx unknown
- 2002-07-18 AU AU2002317360A patent/AU2002317360B2/en not_active Ceased
- 2002-07-18 EP EP02745646A patent/EP1406597A1/en not_active Withdrawn
- 2002-07-18 CA CA002457308A patent/CA2457308A1/en not_active Abandoned
- 2002-07-18 KR KR10-2004-7000801A patent/KR20040032857A/ko not_active Application Discontinuation
- 2002-07-18 CN CNA028184734A patent/CN1556697A/zh active Pending
- 2002-07-18 JP JP2003513528A patent/JP2005501039A/ja active Pending
- 2002-07-18 JP JP2003513528D patent/JP2005519858A/ja active Pending
- 2002-07-18 RU RU2004104950/15A patent/RU2004104950A/ru not_active Application Discontinuation
- 2002-07-18 US US10/484,734 patent/US20060099257A1/en not_active Abandoned
- 2002-07-18 BR BR0211156-0A patent/BR0211156A/pt not_active Application Discontinuation
- 2002-07-18 WO PCT/GB2002/003286 patent/WO2003007919A1/en active Application Filing
- 2002-07-18 MX MXPA04000544A patent/MXPA04000544A/es unknown
-
2004
- 2004-02-16 ZA ZA200401216A patent/ZA200401216B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JP2005519858A (ja) | 2005-07-07 |
RU2004104950A (ru) | 2005-03-10 |
AU2002317360B2 (en) | 2006-08-17 |
JP2005501039A (ja) | 2005-01-13 |
GB0117618D0 (en) | 2001-09-12 |
CA2457308A1 (en) | 2003-01-30 |
US20060099257A1 (en) | 2006-05-11 |
MXPA04000544A (es) | 2005-06-06 |
KR20040032857A (ko) | 2004-04-17 |
WO2003007919A1 (en) | 2003-01-30 |
ZA200401216B (en) | 2005-03-17 |
CN1556697A (zh) | 2004-12-22 |
EP1406597A1 (en) | 2004-04-14 |
IL159876A0 (en) | 2004-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0211156A (pt) | Forma de dosagem de liberação controlada com taxas de liberação variáveis | |
DE69626545D1 (de) | Elektrostatische beschichtung | |
DE69621826T2 (de) | Film- oder schicht-abscheidung und pulver herstellung | |
CA2145513A1 (en) | Pharmaceutical Tablet Capable of Liberating One or More Drugs at Different Release Rates | |
DE60224520D1 (de) | Tabletten mit farbigen mustern und deren herstellung | |
BR9807368A (pt) | Comprimidos de oxacarvazepina revestidos com pelìcula | |
BRPI0509194A (pt) | formulação e método de comprimido revestido | |
WO2002011702A3 (en) | Hydrogel-driven drug dosage form | |
DE60237372D1 (de) | Magenretentionssystem mit kontrollierter arzneimittelfreisetzung | |
DE60336671D1 (de) | Dosierform mit einem innenkern und mindestens zwei bezugsschichten | |
BR0312445A (pt) | Sistemas multiunitários para disponibilização de fármaco de liberação modificada | |
NZ512683A (en) | Taste-masked pharmaceutical particles that are suitable for making chewable tablets | |
GB0204772D0 (en) | Pharmaceutical dosage forms | |
ATE251449T1 (de) | Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe | |
BR0315142A (pt) | Cápsula, tablete, grânulo ou grânulo fino, e, cápsula de liberação prolongada | |
ATE428407T1 (de) | Oralen arzneiform mit oeffnungen in der äusseren hülle | |
MX9203168A (es) | Substrato provisto de multiples capas, procedimiento para la formacion de dichas capas y composicion de revestimiento. | |
BR9705421A (pt) | Componente de fundente revestido | |
GB2316086A (en) | Powder coating composition for electrostatic coating of pharmaceutical substrates | |
DE60228479D1 (de) | Papierstrichlatex mit ionischem monomer | |
AU2001289126A1 (en) | Metered dose inhaler can coated two or more times with fluorocarbon polymers | |
ATE350021T1 (de) | Pharmazeutische formulierung enthaltend trägerkügelchen mit aufgebrachter schicht aus valaciclovir | |
WO2002080033A3 (en) | Peer distributed embedded web server system | |
TW200628529A (en) | Inorganic material film, inorganic material film structure, the process of manufacture them and a transfer film | |
ATE195871T1 (de) | Steroid enthaltende dosierungsformen mit einer steroiddichten umhüllung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |